Description: SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
Home Page: sanuwave.com
11495 Valley View Road
Eden Prairie,
MN
55344
United States
Phone:
(952) 656-1029
Officers
| Name | Title |
|---|---|
| Mr. Morgan C. Frank | CEO & Chairman |
| Mr. Timothy Hendricks | Executive Vice President of Sales for U.S. Wound Business |
| Mr. Andrew Walko | President |
| Mr. Peter Sorensen | Chief Financial Officer |
| Mr. Peter Stegagno | Chief Operating Officer |
| Dr. Iulian Cioanta Ph.D. | Chief Science & Technology Officer |
| Ms. Nanci Gilmore | Vice President of Commercial Operations |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 31 |